메뉴 건너뛰기




Volumn 143, Issue 2, 2007, Pages 335-338

Anti-VEGF Bevacizumab (Avastin®) for Radiation Optic Neuropathy

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

EID: 33846362539     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.09.014     Document Type: Article
Times cited : (86)

References (5)
  • 1
    • 3142520103 scopus 로고    scopus 로고
    • Radiation-induced optic neuropathy: still no treatment
    • Miller N.R. Radiation-induced optic neuropathy: still no treatment. Clin Experiment Ophthalmol 32 (2004) 233-235
    • (2004) Clin Experiment Ophthalmol , vol.32 , pp. 233-235
    • Miller, N.R.1
  • 2
    • 0000963854 scopus 로고    scopus 로고
    • Ophthalmic brachytherapy: treatment of choroidal melanoma and retinoblastoma
    • Peyman G.A., Meffert S., Conway M.D., and Chou F. (Eds), Martin Dunitz, London, United Kingdom
    • Finger P.T., and Murphree A.L. Ophthalmic brachytherapy: treatment of choroidal melanoma and retinoblastoma. In: Peyman G.A., Meffert S., Conway M.D., and Chou F. (Eds). Vitreoretinal surgical techniques (2001), Martin Dunitz, London, United Kingdom 403-418
    • (2001) Vitreoretinal surgical techniques , pp. 403-418
    • Finger, P.T.1    Murphree, A.L.2
  • 3
    • 33745191186 scopus 로고    scopus 로고
    • Hyperbaric oxygen therapy for radiation-induced optic neuropathy
    • Levy R.L., and Miller N.R. Hyperbaric oxygen therapy for radiation-induced optic neuropathy. Ann Acad Med Singapore 35 (2006) 151-157
    • (2006) Ann Acad Med Singapore , vol.35 , pp. 151-157
    • Levy, R.L.1    Miller, N.R.2
  • 4
    • 0027500810 scopus 로고
    • The combined effect of diabetes and ionizing radiation on the retinal vasculature of the rat
    • Gardiner T.A., Amoaku W.M., and Archer D.B. The combined effect of diabetes and ionizing radiation on the retinal vasculature of the rat. Curr Eye Res 12 (1993) 1009-1014
    • (1993) Curr Eye Res , vol.12 , pp. 1009-1014
    • Gardiner, T.A.1    Amoaku, W.M.2    Archer, D.B.3
  • 5
    • 20144368709 scopus 로고    scopus 로고
    • Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration
    • Rosenfeld P.J., Schwartz S.D., Blumenkranz M.S., et al. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology 112 (2005) 1048-1053
    • (2005) Ophthalmology , vol.112 , pp. 1048-1053
    • Rosenfeld, P.J.1    Schwartz, S.D.2    Blumenkranz, M.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.